Navigation Links
Cardiogenesis Announces Preliminary Clinical Results With the PHOENIX System Combining TMR + Stem Cells
Date:6/12/2008

IRVINE, Calif., June 12 /PRNewswire-FirstCall/ -- Cardiogenesis Corporation (Pink Sheets: CGCP), a leading developer of surgical products for cardiac revascularization, today announced a scientific presentation that describes the use of the PHOENIX delivery system combining transmyocardial revascularization (TMR) with autologous bone marrow derived stem cells.

The presentation titled "Transmyocardial Revascularization Combined with Concentrated Autologous Stem Cells," is to be presented by Guillermo Reyes, M.D. of La Princesa Hospital (Madrid, Spain) at the 10th annual meeting of the International Society of Minimally Invasive Cardiothoracic Surgeons (ISMICS) on June 12, 2008 in Boston. The abstract of the presentation is available at http://www.ismics.org/abstracts/2008/MP5.html.

Dr. Reyes reports on the use of the PHOENIX system, a Holmium YAG Laser TMR and biologic combination delivery system manufactured by Cardiogenesis. Dr. Reyes is presenting on a series of 9 patients with diffuse coronary artery disease and medically refractory class III/IV angina that were treated by the application of TMR in combination with bone marrow derived stem cells in targeted ischemic heart muscle. At an average follow up of 6 months:
-- All patients experienced at least a two class reduction in angina;

-- 7 patients were angina free;

-- Sublingual nitrate use pre procedure was 37 per patient per month

compared to 4 per month at follow up (p=0.03);

-- and there were no perioperative adverse events including no

arrhythmias.

The hypothesis for the study is an enhanced cell uptake and angiogenic effect when delivering concentrated bone marrow derived stem cells to the stimulated tissue border zone surrounding the TMR channels at the time of surgery.

"These initial clinical results utilizing the PHOENIX delivery system are very prom
'/>"/>

SOURCE Cardiogenesis Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Targeted Genetics Announces Positive Phase 1/2 tgAAC94 Data Presented at Annual European Congress of Rheumatology
2. Iomai Announces Publication in The Lancet of Phase II Study Demonstrating Significant Efficacy of Travelers Diarrhea Vaccine
3. Morria Biopharmaceuticals Plc Announces Regulatory Approval to Commence Phase II Clinical Study of MRX-4 in Allergic Rhinitis
4. CuraGen Announces Expansion of CR011-vcMMAE Phase II Trial in Melanoma
5. NeurogesX Announces Publication of NGX-4010 Phase 3 HIV-Neuropathy Study Results in Neurology
6. Alexza Announces Preliminary Results From its AZ-002 (Staccato(R) Alprazolam) Phase 2a Proof-of-Concept Trial in Patients With Panic Disorder
7. Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombinant Human Hyaluronidase (rHuPH20) With Humulin R(R) and with Humalog(R) Yields Faster, More Physiologic Insulin Kinetics and Better Predictability
8. ASPIRE Independent Review Board Announces 10 Ways to Protect Participants Rights in Clinical Drug Trials and Optimize Results From Research
9. Atrium Medical Corporation Announces First Implant of First-in-Man CINATRA(TM) Voclosporin Coated Coronary Stent
10. Sangamo BioSciences Announces Presentation of Phase 1b ZFP Therapeutic Data at American Diabetes Association Meeting
11. Regado Biosciences Announces Publication in Circulation of Clinical Trial Results of REG1 Anticoagulation System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... , July 10, 2014  The U.S. Department ... three-year grant to University Hospitals (UH) Case Medical Center ... new national model aimed at improving care for patients ... Care," the project will test a unique model developed ... with late-stage disease, significant comorbidities, or demonstrated need for ...
(Date:7/10/2014)... 2014  RESMED INC. (NYSE: RMD ) today ... year ended June 30, 2014 results on Thursday, July 31, ... press release with ResMed,s results will be issued after 1:00 ... webcast to discuss operating results and future outlook. ... US Pacific Time and the live webcast of the call ...
(Date:7/10/2014)... Quebec , July 10, 2014  Valeant Pharmaceuticals ... VRX) today announced it has completed the sale to ... and Dysport owned or held by Valeant for $1.4 ... with Nestle S.A, which recently completed its acquisition of ... the divestiture of our products to a company that ...
Breaking Medicine Technology:University Hospitals Case Medical Center Awarded $4.7 Million Grant from U.S. Department of Health and Human Services 2University Hospitals Case Medical Center Awarded $4.7 Million Grant from U.S. Department of Health and Human Services 3University Hospitals Case Medical Center Awarded $4.7 Million Grant from U.S. Department of Health and Human Services 4ResMed To Announce Fourth Quarter And Fiscal Year-End 2014 Results 2
(Date:7/12/2014)... According to the new market research report ... and Naval Systems) - Global Forecasts and Analysis to ... Radar market are estimated to be $6.08 billion in ... 5.97% to reach $8.61 billion by 2020. , Browse ... spread through 161 pages and in-depth TOC on "Security ...
(Date:7/12/2014)... York, NY (PRWEB) July 12, 2014 ... steady growth over the past five years, buoyed by ... agricultural sector's supply management system. “Eggs are a relatively ... result, per capita egg consumption generally grows in line ... Industry Analyst Will McKitterick. Furthermore, demand for new specialty ...
(Date:7/12/2014)... The rise in the number of mobility devices around ... to suit the upsurge. Virtualization has become a growing ... technologies. The data traffic has increased by several folds ... resulted in larger and more complex networks. These global ... market. , The North American (NA) region is expected ...
(Date:7/12/2014)... 2014 The "North ... Devices Market by Angioplasty Balloon (Plain/Old, ... OCT), IVC Filter (Retrievable), Endovascular Stent ... and studies the major market drivers, ... and Canada. , Browse 108 market ...
(Date:7/12/2014)... Security Analytics market is estimated to grow from $1,961.8 ... an expected CAGR of 9.7% for the period between ... number of security breaches, continued line of sophisticated attacks, ... are enormous. Vendors in the security analytics market are ... better and more secure systems. , There has been ...
Breaking Medicine News(10 mins):Health News:Security and Surveillance Radar Market Estimated to Reach $8.61 Billion by 2020 – New Report by MarketsandMarkets 2Health News:Security and Surveillance Radar Market Estimated to Reach $8.61 Billion by 2020 – New Report by MarketsandMarkets 3Health News:Security and Surveillance Radar Market Estimated to Reach $8.61 Billion by 2020 – New Report by MarketsandMarkets 4Health News:Chicken Egg Production in Canada Industry Market Research Report Now Available from IBISWorld 2Health News:Chicken Egg Production in Canada Industry Market Research Report Now Available from IBISWorld 3Health News:North America Software Defined Network (SDN) Market Worth $1,443.8 Million by 2019 - New Report by MicroMarket Monitor 2Health News:North America Software Defined Network (SDN) Market Worth $1,443.8 Million by 2019 - New Report by MicroMarket Monitor 3Health News:North America Software Defined Network (SDN) Market Worth $1,443.8 Million by 2019 - New Report by MicroMarket Monitor 4Health News:North America Software Defined Network (SDN) Market Worth $1,443.8 Million by 2019 - New Report by MicroMarket Monitor 5Health News:North American Interventional Cardiology & Peripheral Vascular Devices Market - New Report by MarketsandMarkets 2Health News:North American Interventional Cardiology & Peripheral Vascular Devices Market - New Report by MarketsandMarkets 3Health News:North American Interventional Cardiology & Peripheral Vascular Devices Market - New Report by MarketsandMarkets 4Health News:North American Interventional Cardiology & Peripheral Vascular Devices Market - New Report by MarketsandMarkets 5Health News:North America Security Analytics Market Worth $1,215.2 Million by 2019 - New Report by MicroMarket Monitor 2Health News:North America Security Analytics Market Worth $1,215.2 Million by 2019 - New Report by MicroMarket Monitor 3Health News:North America Security Analytics Market Worth $1,215.2 Million by 2019 - New Report by MicroMarket Monitor 4
... News) -- For people with tinnitus, which features chronic ... ears, poor sleep makes it even more difficult to ... The study included 117 tinnitus patients treated at Henry ... more severe the patients, insomnia, the greater their complaints ...
... News) -- Air quality in America,s most polluted cities has ... report from the American Lung Association. Even Los Angeles, ... in 13 years, the association noted. Santa Fe, N.M. leads ... the nation. Despite progress in reducing the level of ...
... HealthDay Reporter , WEDNESDAY, April 25 (HealthDay News) ... of autism -- repetitive behavior and abnormal social ... The drug, GRN-529, targets glutamate, a major ... activating neurons, or brain cells. Researchers believe the ...
... of dandruff the embarrassing nuisance that, by some accounts, ... much-needed new treatment for the condition,s flaking and itching. The ... Journal of Medicinal Chemistry . Claudiu T. Supuran and ... skin cells from the scalp. In people without dandruff, it ...
... Mich.Brain scans of a small group of people can predict ... by researchers from the University of Michigan, the University of ... The findings are relevant to political advertising, commercial market research ... imaging from a diagnostic to a predictive tool. As ...
... reporting that the mucus lining the stomachs of pigs could ... use as broad-spectrum anti-viral agents to supplement baby formula and ... protect against a range of viral infections. Their study appears ... Katharina Ribbeck and colleagues point out that mucus, which coats ...
Cached Medicine News:Health News:Poor Sleep Heightens 'Ringing Ear' Disease Symptoms: Study 2Health News:Air Quality Improving in Many U.S. Cities: Report 2Health News:Air Quality Improving in Many U.S. Cities: Report 3Health News:Experimental Drug Eases Autistic Behaviors in Mice 2Health News:Experimental Drug Eases Autistic Behaviors in Mice 3Health News:Experimental Drug Eases Autistic Behaviors in Mice 4Health News:Small 'neural focus groups' predict anti-smoking ad success 2Health News:Small 'neural focus groups' predict anti-smoking ad success 3
... The Infinity Lithium single liquid stable ... convenience of single liquid stability to ... error and provide quick result turnaround ... Infinity Lithium reagent provides a long ...
... Infinity Cholesterol powder reagent is intended ... of Cholesterol in serum. , Infinity ... only provides excellent stability once reconstituted ... and correlation against existing assays. The ...
... Infinity AST (GOT) powder reagent once reconstituted ... single liquid stability to help maximize laboratory ... result turnaround time. The patented technology of ... a long shelf life and stability once ...
... forceps are extremely delicate and if repairs ... they can easily be damaged beyond repair ... endoscopes. , On the other hand, with ... can have a virtually indefinite lifespan. The ...
Medicine Products: